Annual EBITDA
-$58.47 M
-$30.70 M-110.51%
December 31, 2023
Summary
- As of February 12, 2025, KYTX annual EBITDA is -$58.47 million, with the most recent change of -$30.70 million (-110.51%) on December 31, 2023.
- During the last 3 years, KYTX annual EBITDA has fallen by -$32.71 million (-126.98%).
- KYTX annual EBITDA is now -126.98% below its all-time high of -$25.76 million, reached on December 1, 2021.
Performance
KYTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$33.90 M
-$5.67 M-20.08%
September 30, 2024
Summary
- As of February 12, 2025, KYTX quarterly EBITDA is -$33.90 million, with the most recent change of -$5.67 million (-20.08%) on September 30, 2024.
- Over the past year, KYTX quarterly EBITDA has dropped by -$13.74 million (-68.18%).
- KYTX quarterly EBITDA is now -319.53% below its all-time high of -$8.08 million, reached on December 1, 2022.
Performance
KYTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$108.46 M
-$18.93 M-21.14%
September 30, 2024
Summary
- As of February 12, 2025, KYTX TTM EBITDA is -$108.46 million, with the most recent change of -$18.93 million (-21.14%) on September 30, 2024.
- Over the past year, KYTX TTM EBITDA has dropped by -$49.99 million (-85.49%).
- KYTX TTM EBITDA is now -1242.17% below its all-time high of -$8.08 million, reached on December 1, 2022.
Performance
KYTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KYTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -110.5% | -68.2% | -85.5% |
| 3 y3 years | -127.0% | -68.2% | -85.5% |
| 5 y5 years | -127.0% | -68.2% | -85.5% |
KYTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -127.0% | at low | -319.5% | at low | -1242.2% | at low |
| 5 y | 5-year | -127.0% | at low | -319.5% | at low | -1242.2% | at low |
| alltime | all time | -127.0% | at low | -319.5% | at low | -1242.2% | at low |
Kyverna Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$33.90 M(+20.1%) | -$108.46 M(+21.1%) |
| Jun 2024 | - | -$28.23 M(+7.9%) | -$89.54 M(+21.1%) |
| Mar 2024 | - | -$26.17 M(+29.8%) | -$73.93 M(+26.4%) |
| Dec 2023 | -$58.47 M | -$20.16 M(+34.6%) | -$58.47 M(+26.0%) |
| Sep 2023 | - | -$14.98 M(+18.6%) | -$46.40 M(+47.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$12.63 M(+18.0%) | -$31.42 M(+67.2%) |
| Mar 2023 | - | -$10.71 M(+32.5%) | -$18.79 M(+132.5%) |
| Dec 2022 | -$27.78 M(+7.8%) | - | - |
| Dec 2022 | - | -$8.08 M | -$8.08 M |
| Dec 2021 | -$25.76 M | - | - |
FAQ
- What is Kyverna Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual EBITDA year-on-year change?
- What is Kyverna Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly EBITDA year-on-year change?
- What is Kyverna Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Kyverna Therapeutics?
- What is Kyverna Therapeutics TTM EBITDA year-on-year change?
What is Kyverna Therapeutics annual EBITDA?
The current annual EBITDA of KYTX is -$58.47 M
What is the all time high annual EBITDA for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual EBITDA is -$25.76 M
What is Kyverna Therapeutics annual EBITDA year-on-year change?
Over the past year, KYTX annual EBITDA has changed by -$30.70 M (-110.51%)
What is Kyverna Therapeutics quarterly EBITDA?
The current quarterly EBITDA of KYTX is -$33.90 M
What is the all time high quarterly EBITDA for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly EBITDA is -$8.08 M
What is Kyverna Therapeutics quarterly EBITDA year-on-year change?
Over the past year, KYTX quarterly EBITDA has changed by -$13.74 M (-68.18%)
What is Kyverna Therapeutics TTM EBITDA?
The current TTM EBITDA of KYTX is -$108.46 M
What is the all time high TTM EBITDA for Kyverna Therapeutics?
Kyverna Therapeutics all-time high TTM EBITDA is -$8.08 M
What is Kyverna Therapeutics TTM EBITDA year-on-year change?
Over the past year, KYTX TTM EBITDA has changed by -$49.99 M (-85.49%)